Dec 20, 2017· Comment from Association for Accessible Medicines· FDA-2012-D-0880-0025
Comments from The Association for Accessible Medicines (AAM) on behalf of our member companies, regarding Docket FDA-2012-D-0880-0023: Assessing User Fees Under the Generic Drug User Fee Amendments of 2017.